These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20217508)

  • 1. Molecular pathways underlying the pathogenesis of pancreatic alpha-cell dysfunction.
    Kawamori D; Welters HJ; Kulkarni RN
    Adv Exp Med Biol; 2010; 654():421-45. PubMed ID: 20217508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose control of glucagon secretion-'There's a brand-new gimmick every year'.
    Gylfe E
    Ups J Med Sci; 2016 May; 121(2):120-32. PubMed ID: 27044660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
    Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M
    Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin modulation of glucagon secretion: the role of insulin and other factors in the regulation of glucagon secretion.
    Kawamori D; Kulkarni RN
    Islets; 2009; 1(3):276-9. PubMed ID: 21099284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.
    Cryer PE
    Endocrinology; 2012 Mar; 153(3):1039-48. PubMed ID: 22166985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon secretion from pancreatic α-cells.
    Briant L; Salehi A; Vergari E; Zhang Q; Rorsman P
    Ups J Med Sci; 2016 May; 121(2):113-9. PubMed ID: 27044683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth factor signalling in the regulation of α-cell fate.
    Kawamori D; Akiyama M; Hu J; Hambro B; Kulkarni RN
    Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():21-30. PubMed ID: 21824253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural regulation of pancreatic islet cell mass and function.
    Thorens B
    Diabetes Obes Metab; 2014 Sep; 16 Suppl 1():87-95. PubMed ID: 25200301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin and insulin mediate glucose-inhibited glucagon secretion in the pancreatic α-cell by lowering cAMP.
    Elliott AD; Ustione A; Piston DW
    Am J Physiol Endocrinol Metab; 2015 Jan; 308(2):E130-43. PubMed ID: 25406263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathways of Glucagon Secretion and Trafficking in the Pancreatic Alpha Cell: Novel Pathways, Proteins, and Targets for Hyperglucagonemia.
    Asadi F; Dhanvantari S
    Front Endocrinol (Lausanne); 2021; 12():726368. PubMed ID: 34659118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic network control of glucagon secretion and counterregulation.
    Farhy LS; McCall AL
    Methods Enzymol; 2009; 467():547-581. PubMed ID: 19897107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin regulates islet alpha-cell function by reducing KATP channel sensitivity to adenosine 5'-triphosphate inhibition.
    Leung YM; Ahmed I; Sheu L; Gao X; Hara M; Tsushima RG; Diamant NE; Gaisano HY
    Endocrinology; 2006 May; 147(5):2155-62. PubMed ID: 16455778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha cell dysfunction in type 1 diabetes.
    Yosten GLC
    Peptides; 2018 Feb; 100():54-60. PubMed ID: 29412832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose and ATP levels in pancreatic islet tissue of normal and diabetic rats.
    Matschinsky FM; Pagliara AS; Stillings SN; Hover BA
    J Clin Invest; 1976 Nov; 58(5):1193-200. PubMed ID: 136453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalase expression in pancreatic alpha cells of diabetic and non-diabetic mice.
    Bloch K; Shichman E; Vorobeychik M; Bloch D; Vardi P
    Histochem Cell Biol; 2007 Feb; 127(2):227-32. PubMed ID: 17102991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Native pancreatic alpha-cell adaptation in streptozotocin-induced diabetic primates: importance for pig islet xenotransplantation.
    Dufrane D; Maillart JF; Aouassar N; Goebbels RM; Guiot Y; Gianello P
    Xenotransplantation; 2009; 16(3):152-63. PubMed ID: 19566655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in somatostatin concentration in pancreas and other tissues of streptozotocin diabetic rats.
    Patel YC; Cameron DP; Bankier A; Malaisse-Lagae F; Ravazzola M; Studer P; Orci L
    Endocrinology; 1978 Sep; 103(3):917-23. PubMed ID: 154402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
    Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
    Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin and glucose as modulators of the amino acid-induced glucagon release in the isolated pancreas of alloxan and streptozotocin diabetic rats.
    Pagliara AS; Stillings SN; Haymond MW; Hover BA; Matschinsky FM
    J Clin Invest; 1975 Feb; 55(2):244-55. PubMed ID: 123928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.